Pharmabiz1 天
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for ...
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy: Tokyo Saturday, January 11, 2025, 10:00 Hrs [IST] Astellas Pharma In ...
Pharmabiz1 天
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize ...
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea: Milan Saturday, January 11, 2025, 16:00 Hrs [IST] ...
Pharmabiz1 天
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation: London, UK Saturday, January 11, 2025, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...
Pharmabiz2 天
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial: Potomac, Maryland Friday, January 10, 2025, 16:30 Hrs [IST] IGC Pharma, Inc, an AI-powe ...
Pharmabiz1 天
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides ...
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025: Philadelphia Saturday, January 11, 2025, 17:00 Hrs [IST] FORE Bioth ...
Pharmabiz2 天
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring ...
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...
Pharmabiz2 天
Medi Assist’s 2024 findings shed light on rising costs, incidence and demography wise ...
Our Bureau, Mumbai Friday, January 10, 2025, 15:40 Hrs [IST] ...
Pharmabiz2 天
Impose 5-15% duty on imports of medical devices and monitor MRP against import landed cost ...
Impose 5-15% duty on imports of medical devices and monitor MRP against import landed cost, demands AiMeD: Our Bureau, New Delhi Friday, January 10, 2025, 16:10 Hrs [IST] The Asso ...
Pharmabiz2 天
AI to revolutionise hair loss diagnosis and treatment, say experts
AI to revolutionise hair loss diagnosis and treatment, say experts: Our Bureau, New Delhi Friday, January 10, 2025, 16:20 Hrs [IST] The integration of AI marks a significant leap ...
Pharmabiz1 天
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology: Ingelheim Saturday, January 11, 2025, 14:00 Hrs [IST] Boehringer Ingelheim and Synaf ...
Pharmabiz2 天
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner: Manila, Philippines Friday, January 10, 2025, 17:00 Hrs [IST] Zuellig Pharma, a leading healthcare solu ...
Pharmabiz1 天
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor ...
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...